KOVALTRY® Conversations:

Register to share your story

Join the Conversation!

Register with us to let us know if you would like to be contacted to share your patient or caregiver story—your experiences could be featured in our KOVALTRY® Conversations.

*Indicates required field

*First Name

*Last Name

Street Address

*Zip Code

Zip Code is invalid

*Email Address

*Select which statement best describes you

I have hemophilia A

I am the main care partner/parent for someone with hemophilia A

I have hemophilia A

I am the main care partner/parent for someone with hemophilia A

By clicking above, I agree to allow Bayer to contact me about potentially being featured in KOVALTRY^® Conversations (people who use KOVALTRY^® sharing their stories about living with hemophilia A and treatment with KOVALTRY^®).

By submitting this form, I agree to receiving news, announcements, and information about hemophilia A. Privacy Policy

I confirm that I am 18 years of age or older

You must be 18 years of age or older to register. Your legal guardian is permitted to register on your behalf. Simply invite them to fill out this registration form.

INDICATION FOR KOVALTRY®

KOVALTRY® is a medicine used to replace clotting factor (Factor VIII or antihemophilic factor) that is missing in people with hemophilia A.

KOVALTRY is used to treat and control bleeding in adults and children with hemophilia A. KOVALTRY can reduce the number of bleeding episodes in adults and children with hemophilia A when used regularly (prophylaxis). Your healthcare provider may give you KOVALTRY when you have surgery.

KOVALTRY is not used to treat von Willebrand Disease.

IMPORTANT SAFETY INFORMATION

You should not use KOVALTRY if you are allergic to rodents (like mice and hamsters) or any ingredients in KOVALTRY.

Tell your healthcare provider if you have heart disease or are at risk for heart disease.

The common side effects of KOVALTRY are fever, headache, and rash, in addition to inhibitors in patients who were not previously treated or minimally treated with Factor VIII products.

Your body may make antibodies, called “inhibitors” against KOVALTRY, which may stop KOVALTRY from working properly. If your bleeding is not adequately controlled, it could be due to the development of Factor VIII inhibitors. Consult with your healthcare provider to make sure you are carefully monitored with blood tests for the development of inhibitors to Factor VIII.

Allergic reactions may occur with KOVALTRY. Call your healthcare provider right away and stop treatment if you get tightness of the chest or throat, dizziness, decrease in blood pressure, and nausea.

Tell your healthcare provider about any side effect that bothers you or that does not go away.

Call your healthcare provider right away if bleeding is not controlled after using KOVALTRY.

For additional important risk and use information, please see full Prescribing Information.